LAVAL, Quebec, June 16, 2020 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) today announced that Paul S.
Herendeen, executive vice president and chief financial officer,
Arthur J. Shannon, senior vice
president and head of Investor Relations and Communications, and
William Woodfield, vice president
and treasurer, are scheduled to participate at the virtual Goldman
Sachs Leveraged Finance Conference on June
25, 2020, at 11:25 a.m.
EDT.
A live webcast and audio archive of the events will be available
on the Investor Relations page of the Bausch Health Companies Inc.
web site at:
http://ir.bauschhealth.com/events-and-presentations/2020.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-to-participate-at-goldman-sachs-annual-leveraged-finance-conference-301075178.html
SOURCE Bausch Health Companies Inc.